HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis

Author： Yilmaz A.   Reiss C.   Tantawi O.   Weng A.   Stumpf C.   Raaz D.   Ludwig J.   Berger T.   Steinkasserer A.   Daniel W.G.   Garlichs C.D.  

Publisher： Elsevier

ISSN： 0021-9150

Source： Atherosclerosis, Vol.172, Iss.1, 2004-01, pp. : 85-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Direct Vascular Effects of HMG-CoA Reductase Inhibitors

By Laufs U.   Liao J.K.  

Trends in Cardiovascular Medicine, Vol. 10, Iss. 4, 2000-05 ,pp. : 143-148

Elsevier

Access to resources Recommend Favorite

HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice

By Zineh Issam  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 191-206

Future Medicine

Access to resources Recommend Favorite

Advantages of Lipid-Lowering Therapy in Cerebral Ischemia: Role of HMG-CoA Reductase Inhibitors

By  

Cerebrovascular Diseases, Vol. 11, Iss. 1, 2010-04 ,pp. : 85-95

Karger

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA

By  

Current Vascular Pharmacology, Vol. 14, Iss. 4, 2016-07 ,pp. : 345-352

Bentham Science Publishers

Access to resources Recommend Favorite

Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 143-152

Bentham Science Publishers

Access to resources Recommend Favorite